# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-000313
Filing Date
2025-02-04
Accepted
2025-02-04 07:04:09
Documents
2
Period of Report
2025-02-04

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | zk2532647.htm | 6-K | 48622
2 |  | image00001.jpg | GRAPHIC | 672379
| Complete submission text file | 0001178913-25-000313.txt |  | 975531

Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 25585278
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)